Human breast carcinoma cancer-Associated Fibroblasts (CAFs): 1,000,000 cells/products/human-breast-cancer-associate-fibroblasts-1-000-000-cells-per-vial
Vitro Biopharma offers human breast carcinoma cancer-associated fibroblasts (CAFs) for in-vitro research use. They come from well-characterized donor samples and are available from multiple donors.
Human colorectal Adenocarcinoma Cancer-Associated Fibroblasts (CAFs): 1,000,000 cells/products/human-colorectal-adenocarcinoma-cancer-associate-fibroblasts-1-000-000-cells-per-vial
Vitro Biopharma offers human colorectal adenocarcinoma cancer-associated fibroblasts (CAFs) for in-vitro research use. They come from well-characterized donor samples and are available from multiple donors.
Human lung squamous cell carcinoma cancer-Associated Fibroblasts (CAFs): 1,000,000 cells/products/human-lung-squamous-cell-carcinoma-cancer-associate-fibroblasts-1-000-000-cells-per-vial
Vitro Biopharma offers human lung squamous cell carcinoma cancer-associated fibroblasts (CAFs) for in-vitro research use. They come from well-characterized donor samples and are available from multiple donors.
Human Pancreatic Adenocarcinoma Cancer-Associated Fibroblasts (CAFs): 1,000,000 cells/products/human-pancreatic-stellate-cancer-associate-fibroblasts-1-000-000-cells-per-vial
Vitro Biopharma offers human pancreatic adenocarcinoma cancer-associated fibroblasts (CAFs) for in-vitro research use. They come from well-characterized donor samples and are available from multiple donors.

Homepage

1 page

Homepage/
Vitro Biopharma is a biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.